Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Faeth Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 35.34 · gapped above the open, then crossed back over prior close. High/low 39.33 at 9:45 am ET, 35.30 at 3:15 pm ET.
45 institutional managers report a position in Faeth Therapeutics, Inc. worth $351.8M between them, filed on form 13F for the quarter ending 2026-06-30. 12 of them hold 80% of it, the largest being Suvretta Capital Management, LLC at 14.35%.
20 more managers in the register
12 managers hold 80% of the $351.8M institutional base. The other 33 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Suvretta Capital Management, LLC, RA Capital Management, LLC, Franklin Resources Inc +3 more · 14.35% of FTH, 34.85% of BNTC
via Suvretta Capital Management, LLC, Caligan Partners LP, RA Capital Management, LLC +7 more · 14.35% of FTH, 7.54% of AURA
via RA Capital Management, LLC, Caligan Partners LP, Trails Edge Capital Partners, LP +6 more · 5.13% of FTH, 7.42% of LBRX
via Baker Bros. Advisors LP, Vivo Capital, LLC, Logos Global Management LP +5 more · 9.14% of FTH, 6.79% of DBVT
via Suvretta Capital Management, LLC, Cormorant Asset Management, LLC, Franklin Resources Inc +4 more · 14.35% of FTH, 8.53% of EYPT
via Cormorant Asset Management, LLC, Balyasny Asset Management LLC, RA Capital Management, LLC +2 more · 7.31% of FTH, 7.51% of HLXC
Managers holding a meaningful stake in FTH also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
FTH (Faeth Therapeutics, Inc.) has 2 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: TAK +0.05%, in healthcare.